Beijing Science Sun Pharmaceutical Co., Ltd.
SZSE:300485.SZ
11.09 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 476.57 | 734.547 | 1,050.805 | 1,094.225 | 1,190.903 | 1,427.751 | 749.987 | 616.238 | 607.138 | 589.846 | 480.212 | 396.013 | 245.023 |
| Kosten van de omzet
| 140.939 | 171.608 | 182.124 | 177.34 | 176.794 | 195.959 | 175.965 | 203.291 | 238.274 | 225.029 | 189.516 | 147.76 | 124.528 |
| Brutowinst
| 335.63 | 562.939 | 868.681 | 916.885 | 1,014.108 | 1,231.792 | 574.022 | 412.947 | 368.864 | 364.817 | 290.696 | 248.253 | 120.495 |
| Brutowinstmarge
| 0.704 | 0.766 | 0.827 | 0.838 | 0.852 | 0.863 | 0.765 | 0.67 | 0.608 | 0.618 | 0.605 | 0.627 | 0.492 |
| Onderzoek- en ontwikkelingskosten
| 77.733 | 100.632 | 103.841 | 71.671 | 50.383 | 31.928 | 16.258 | 27.471 | 29.688 | 32.512 | 16.349 | 14.864 | 0 |
| Algemene en administratieve kosten
| 21.022 | 16.321 | 52.099 | 18.877 | 10.309 | 14.04 | 10.674 | 12.751 | 11.533 | 5.256 | 5.977 | 8.193 | 18.202 |
| Verkoop- en marketingkosten
| 230.428 | 368.842 | 555.164 | 626.671 | 763.06 | 828.431 | 221.02 | 88.829 | 78.254 | 76.755 | 63.152 | 57.181 | 7.494 |
| Verkoop-, algemene en administratieve kosten
| 251.45 | 385.163 | 607.263 | 645.548 | 773.369 | 842.472 | 231.694 | 101.58 | 89.786 | 82.011 | 69.129 | 65.374 | 25.696 |
| Overige kosten
| 72.491 | 133.204 | 149.821 | 13.397 | 1.01 | -0.148 | -1.002 | 1.339 | 0.698 | -14.029 | -2.708 | 6.891 | 5.762 |
| Bedrijfskosten
| 376.666 | 527.775 | 767.045 | 782.636 | 884.983 | 936.654 | 286.41 | 167.125 | 154.448 | 147.017 | 114.557 | 103.323 | 27.76 |
| Bedrijfsresultaat
| 121.736 | 254.636 | 438.999 | 179.916 | 177.166 | 330.766 | 332.388 | 298.955 | 242.544 | 233.908 | 183.869 | 147.48 | 93.119 |
| Bedrijfsresultaat ratio
| 0.255 | 0.347 | 0.418 | 0.164 | 0.149 | 0.232 | 0.443 | 0.485 | 0.399 | 0.397 | 0.383 | 0.372 | 0.38 |
| Totaal overige inkomsten en kosten netto
| 0.427 | -0.02 | 0.025 | -0.626 | -4.426 | -0.148 | -1.002 | 1.238 | 0.698 | 2.172 | 2.951 | 6.891 | 5.762 |
| Inkomen voor belasting
| 122.163 | 254.616 | 439.024 | 179.29 | 172.739 | 330.618 | 331.387 | 300.193 | 243.242 | 236.081 | 186.82 | 154.371 | 98.881 |
| Inkomen voor belasting ratio
| 0.256 | 0.347 | 0.418 | 0.164 | 0.145 | 0.232 | 0.442 | 0.487 | 0.401 | 0.4 | 0.389 | 0.39 | 0.404 |
| Belastingkosten
| 25.755 | 51.966 | 43.89 | 28.007 | 25.185 | 47.457 | 49.855 | 41.847 | 34.014 | 33.651 | 26.066 | 21.79 | 14.181 |
| Nettowinst
| 102.918 | 204.735 | 402.27 | 154.903 | 148.639 | 283.107 | 281.604 | 258.406 | 209.274 | 202.572 | 160.789 | 132.567 | 84.66 |
| Nettowinstmarge
| 0.216 | 0.279 | 0.383 | 0.142 | 0.125 | 0.198 | 0.375 | 0.419 | 0.345 | 0.343 | 0.335 | 0.335 | 0.346 |
| WPA (Winst Per Aandeel)
| 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 | 0.59 | 0.54 | 0.5 | 0.56 | 0.45 | 0.37 | 0.26 |
| Verwaterde WPA
| 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 | 0.59 | 0.54 | 0.5 | 0.56 | 0.45 | 0.37 | 0.26 |
| EBITDA
| -22.149 | 83.675 | 451.225 | 224.276 | 150.463 | 326.817 | 309.277 | 264.52 | 232.7 | 234.833 | 191.822 | 154.181 | 92.829 |
| EBITDA ratio
| -0.046 | 0.114 | 0.429 | 0.205 | 0.126 | 0.229 | 0.412 | 0.429 | 0.383 | 0.398 | 0.399 | 0.389 | 0.379 |